CAS: 937046-98-5; 7-Bromopyrrolo[2,1-F][1,2,4]Triazin-4-Amine

该化合物是一种环环状化合物,其特点是含有溴化三联苯核心,并有一个有矿功能组,这种结构使它成为制药和农用化学研究的宝贵中间体,特别是合成生物活性分子.溴代基亚化物可增强回动性,使诸如Suzuki或Buchwald-Hartwig的选择性交叉反应得以产生,其僵硬的引信系统有助于药物发现应用的稳定性和潜在结合性.该化合物由于敏感性,通常在不热的条件下处理,其纯度和定义明确的结构支持在复杂的合成路径中产生可复制的结果.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号159326-68-8 吡咯并[2,1-F][1,2,... | CAS号159326-68-8 吡咯并[2,1-F][1,2,...

合成工艺路线路线简述

  • 合成目标产物 7-Bromopyrrolo[1,2-F][1,2,4]Triazin-4-Amine 主要起始原料 Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine
  • 159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; 45 Min,-20 °C; 45 Min,-20 °C
    标题:Regioselective Mono-Bromination Of Pyrrolo[2,1-F][1,2,4]Triazin-4-Amine
    作者:Bi,Lei; Fang,Sheng; Zhang,Ran; Yin,Xianzhen; Fu,Chenchao; Et Al
    参考文献:Asian Journal Of Chemistry 日期:2014 卷标:26(20) 页码:7083-7084]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; 1 H,-20 °C1.2 Reagents: Sodium Sulfite Solvents: Water
    标题:Preparation Of Substituted Nucleosides,Nucleotides And Analogs Thereof As Antiviral Agents
    参考文献:World Intellectual Property Organization]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: N-Bromosuccinimide Solvents: Dimethylformamide; 0 °C; 0 °C -> Rt; 8 H,Rt
    标题:Preparation Method Of Remdesivir Intermediate
    参考文献:China]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: Potassium Carbonate Solvents: Dimethylformamide; Rt; 2 H,50 °C
    标题:Preparation Of 7-Halopyrrolo[1,2-F][1,2,4]Triazine-4-Amine Of The Key Intermediate Of Remdesivir
    参考文献:China]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; -40 °C; -40 °C -> 0 °C1.2 Reagents: Sodium Hydroxide Solvents: Water; 0 °C; 3 H,Rt
    标题:Flash Chemistry Approach To Organometallic C-Glycosylation For The Synthesis Of Remdesivir
    作者:Von Keutz,Timo; Williams,Jason D.; Kappe,C. Oliver
    参考文献:Organic Process Research & Development 日期:2021 卷标:25(4) 页码:1015-1021]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; 1 H,-20 °C; -20 °C -> Rt1.2 Reagents: Sodium Sulfite Solvents: Water; Rt
    标题:Synthesis Of 7-Bromopyrrolo[2,1-F][1,2,4]Triazin-4-Amine
    作者:Zheng,Jun; Cao,Guo-Rui
    参考文献:Huaxue Shiji 日期:2020 卷标:42(5) 页码:608-611]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; -40 °C; 15 Min,-40 °C -> 0 °C1.2 Reagents: Sodium Hydroxide Solvents: Water; 2 H,Rt
    标题:Continuous Flow C-Glycosylation Via Metal-Halogen Exchange: Process Understanding And Improvements Toward Efficient Manufacturing Of Remdesivir
    作者:Von Keutz,Timo; Williams,Jason D.; Kappe,C. Oliver
    参考文献:Organic Process Research & Development 日期:2020 卷标:24(10) 页码:2362-2368]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; -15 °C; 45 Min,< -10 °C
    标题:Method For Preparing 7-Bromopyrrolo[2,1-F][1,2,4]Triazin-4-Amine As Gs-441524 Intermediate For Treating Feline Infectious Peritonitis (Fip)
    参考文献:China]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; Rt -> -20 °C; 45 Min,-20 °C; 45 Min,-20 °C1.2 Reagents: Sodium Sulfite Solvents: Water
    标题:Preparation Of Substituted 4-Amino-Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis
    参考文献:World Intellectual Property Organization]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; Rt -> -20 °C; 45 Min,-20 °C; 45 Min,-20 °C1.2 Reagents: Sodium Sulfite Solvents: Water
    标题:Preparation Of Pyrrolo[2,1-F][1,2,4]Triazin-4-Ylamines As Igf-1R Kinase Inhibitors For The Treatment Of Cancer And Other Hyperproliferative Diseases
    参考文献:World Intellectual Property Organization]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; -20 °C; 45 Min,-20 °C
    标题:N-Heterocycle-Containing Derivative And Its Pharmaceutical Application
    参考文献:China]

    36953-44-3 + 463-52-5 = 937046-98-5
    反应条件:1.1 Reagents: Sodium Hydride Solvents: Tert-Butyl Methyl Ether; 5 - 10 °C; 30 Min,Rt1.2 Reagents: Monochloramine Solvents: Dimethylformamide,Tert-Butyl Methyl Ether1.3 90 - 95 °C; 8 H,90 - 95 °C1.4 Reagents: Water; Cooled
    标题:N-Cyano-2,2'-Biphenyldicarboimide As A Cyanation Reagent For Co(Iii)-Catalyzed C-H Cyanation Of Indoles In Ionic Liquids
    作者:Zhang,Jingchao; Zou,Mengqi; Tian,Qinye; Sun,Zhizhong; Chu,Wenyi
    参考文献:Organic Letters 日期:2023 卷标:25(9) 页码:1436-1440]

    159326-68-8 = 937046-98-5
    反应条件:1.1 Reagents: 1,3-Dibromo-5,5-Dimethylhydantoin Solvents: Dimethylformamide; -40 °C; -40 °C -> 0 °C1.2 Reagents: Sodium Sulfite Solvents: Water
    标题:Development Of 4-Heteroarylamino-1'-Azaspiro[oxazole-5,3'-Bicyclo[2.2.2]Octanes] As α7 Nicotinic Receptor Agonists
    作者:Hill,Matthew D.; Fang,Haiquan; King,H. Dalton; Iwuagwu,Christiana I.; Mcdonald,Ivar M.; Et Al
    参考文献:Acs Medicinal Chemistry Letters 日期:2017 卷标:8(1) 页码:133-137]

    = 937046-98-5 [标题:Reaction Conditions
    标题:Aminopyrrolotriazines As Kinase Inhibitors And Their Preparation
    参考文献:World Intellectual Property Organization
7-碘吡咯并[2,1-F][1,2,4]三嗪-4-胺置于三甲基氯硅烷,1,3-二溴-5,5-二甲基海因,苯基氯化镁体系中,用 四氢呋喃,N,N-二甲基甲酰胺 作为反应溶剂,化学反应生成 4-氨基-7-溴吡咯并[2,1-F][1,2,4]三嗪
参考文献:Continuous Flow C-Glycosylation Via Metal-halogen Exchange: Process Understanding And Improvements Toward Efficient Manufacturing Of Remdesivir
标题:Continuous Flow C-Glycosylation Via Metal-halogen Exchange: Process Understanding And Improvements Toward Efficient Manufacturing Of Remdesivir
摘要:As Remdesivir Is The First Approved Treatment For Covid-19 (Sars-Cov-2),Its Production Is Likely To Be Of Vital Importance In The Near Future. Continuous Flow Processing Has Been Demonstrated As A Key Technology In The Manufacturing Of Highvolume Active Pharmaceutical Ingredients And Is Considered For Use In This Synthetic Sequence. In Particular,The Challenging Cglycosylation Of A Pyrrolotriazinamine Via Metal-Halogen Exchange Was Identified As A Transformation With Significant Potential Benefit,As Exemplified By Calorimetric Analysis Of Each Reaction Step. Multiple Simplifications Of This Process Were Attempted In Batch But In General Were Found To Be Unfruitful. The Five-Feed Process Was Then Transferred To A Flow Setup,Where Specific Conditions Were Found To Circumvent Solid Formation And Permit Stable Processing. Detailed Optimization Of Stoichiometries Provided An Improvement Upon Batch Conditions With A Total Residence Time Of <1 Min.
DOI:10.1021/acs.Oprd.0C00370

专利信息


专利号:CN-111793101-A
优先权日:2020-07-17
标题:Process for the synthesis of C-nucleoside compounds

专利号:CN-117126199-A
优先权日:2023-05-17
标题 :A kind of synthesis method of fluremdesivir

专利号:CN-112321589-B
优先权日:2020-02-18
标 题 :Synthesis method of antiviral drug Reidesciclovir and intermediate thereof
安徽华邦药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fine-chemtech.com
企业联系电话:17714198479👤
📞安徽华邦药业有限公司 ⚠️参考联系方式
联系人:销售部
电话:17714198479

传真:QQ 2254784343
邮箱:sales@fine-chemtech.com
通信地址: 安徽省滁州市定远盐化工业园义和路
邮编: 210046
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽省滁州市定远盐化工业园义和路
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海凌凯医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.linkchem.cn
企业联系电话:021-58950110;13124863828👤
📞上海凌凯医药科技有限公司 ⚠️参考联系方式
联系人:张经理
电话:021-58950110;13124863828
手机:13124863828
传真:021- 2096 2272
邮箱:sales@linkchem.cn
通信地址: 上海市浦东新区国际医学园区康新公路3399弄5号楼
邮编: 201204
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市浦东新区国际医学园区康新公路3399弄5号楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东诚汇医药集团有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jnchsd.com
企业联系电话:0531-58897025-13589078718👤
📞山东诚汇医药集团有限公司 ⚠️参考联系方式
联系人:刘吉华
电话:0531-58897025-13589078718
手机:13589078718

邮箱:market@jnchsd.com
通信地址: 济南市高新技术开发区开拓路2350号
邮编: 250101
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市高新技术开发区开拓路2350号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2020)
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知